ID

33750

Beschreibung

Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study; ODM derived from: https://clinicaltrials.gov/show/NCT01963130

Link

https://clinicaltrials.gov/show/NCT01963130

Stichworte

  1. 21.12.18 21.12.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

21. Dezember 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Drug Mechanism NCT01963130

Eligibility Drug Mechanism NCT01963130

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 dm cases and at least 3 months used the same drugs (metformin and gliclazide or metformin and gliclazide and vildagliptin)
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent | Metformin | Gliclazide | vildagliptin

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0025598
UMLS CUI [3]
C0017631
UMLS CUI [4]
C1570906
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
used alcohol and cigarettes
Beschreibung

Alcohol consumption | Tobacco use

Datentyp

boolean

Alias
UMLS CUI [1]
C0001948
UMLS CUI [2]
C0543414
chronic liver disease,
Beschreibung

Chronic liver disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0341439
chronic renal failure,
Beschreibung

Kidney Failure, Chronic

Datentyp

boolean

Alias
UMLS CUI [1]
C0022661
active infection
Beschreibung

Communicable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
patients using certain drugs which may affect portal pressure such as propronalol,
Beschreibung

Pharmaceutical Preparations Affecting Portal Pressure | Propranolol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0162523
UMLS CUI [2]
C0033497
calcium channel blockers,
Beschreibung

Calcium Channel Blockers

Datentyp

boolean

Alias
UMLS CUI [1]
C0006684
angiotensin-converting enzyme inhibitors,
Beschreibung

Angiotensin-Converting Enzyme Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C0003015
angiotensin receptor blockers and isosorbit monohydrate
Beschreibung

Angiotensin II receptor antagonist | Other Coding

Datentyp

boolean

Alias
UMLS CUI [1]
C0521942
UMLS CUI [2]
C3846158

Ähnliche Modelle

Eligibility Drug Mechanism NCT01963130

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Metformin | Gliclazide | vildagliptin
Item
type 2 dm cases and at least 3 months used the same drugs (metformin and gliclazide or metformin and gliclazide and vildagliptin)
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C0017631 (UMLS CUI [3])
C1570906 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Alcohol consumption | Tobacco use
Item
used alcohol and cigarettes
boolean
C0001948 (UMLS CUI [1])
C0543414 (UMLS CUI [2])
Chronic liver disease
Item
chronic liver disease,
boolean
C0341439 (UMLS CUI [1])
Kidney Failure, Chronic
Item
chronic renal failure,
boolean
C0022661 (UMLS CUI [1])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Pharmaceutical Preparations Affecting Portal Pressure | Propranolol
Item
patients using certain drugs which may affect portal pressure such as propronalol,
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0162523 (UMLS CUI [1,3])
C0033497 (UMLS CUI [2])
Calcium Channel Blockers
Item
calcium channel blockers,
boolean
C0006684 (UMLS CUI [1])
Angiotensin-Converting Enzyme Inhibitors
Item
angiotensin-converting enzyme inhibitors,
boolean
C0003015 (UMLS CUI [1])
Angiotensin II receptor antagonist | Other Coding
Item
angiotensin receptor blockers and isosorbit monohydrate
boolean
C0521942 (UMLS CUI [1])
C3846158 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video